<DOC>
	<DOCNO>NCT02734823</DOCNO>
	<brief_summary>This pilot research trial study long term effect tyrosine kinase inhibitor therapy ovarian reserve fertility patient chronic myeloid leukemia gastrointestinal stromal tumor . Studying ovary imaging , ovarian reserve marker , hormone level patient receive tyrosine kinase inhibitor therapy may help doctor learn effect tyrosine kinase inhibitor therapy ovarian function fertility .</brief_summary>
	<brief_title>Long Term Effects Tyrosine Kinase Inhibitor Therapy Ovarian Reserve Fertility Patients With Chronic Myeloid Leukemia Gastrointestinal Stromal Tumor</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To collect preliminary information help design study look longitudinal change marker ovarian reserve menstruation premenopausal woman undergo tyrosine kinase inhibitor ( TKI ) therapy . SECONDARY OBJECTIVES : I . Evaluate ovarian response control ovarian hyperstimulation patient elect undergo vitro fertilization ( IVF ) fertility preservation . OUTLINE : Patients undergo transvaginal ultrasound antral follicle analysis collection serum ovarian reserve marker hormonal analysis TKI therapy 12 , 24 , 48 week .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myelogenous , Chronic , BCR-ABL Positive</mesh_term>
	<mesh_term>Gastrointestinal Stromal Tumors</mesh_term>
	<criteria>Diagnosed chronic myeloid leukemia ( CML ) , gastrointestinal stromal tumor ( GIST ) , non metastatic cancer TKI first line agent Premenopausal ( menses time precede 12 consecutive month ) Has undergone hysterectomy bilateral oophorectomy Willing use nonhormonal ( ie : barrier method abstinence ) form contraception one year study Patients chemotherapy radiotherapy past Patients may receive investigational agent Patients must pregnant nursing Other medical condition treatment affect hormonal level ( potentially confound interpretation result ) Patients ongoing hormonal contraception unwilling unable discontinue eligible</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>